Clinical outcomes of a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months' follow-up. Results from the DANBIO registry.

Bente Glintborg, Inge Juul Sørensen, Anne Gitte Loft, Jakob Espesen, Dorte Vendelbo Jensen, Kamilla Danebod, Sabine Sparre Dieperink, Oliver Hendricks, Inger Marie Jensen Hansen, Asta Linauskas, Salome Kristensen, Lis Smedegaard Andersen, Mohammad Hossein, Henrik Nordin, Birgitte Lange Andersen, Stavros Chrysidis, Johnny Lillelund Raun, Hanne Merete Lindegaard, Natalia Manilo, Jolanta GrydehøjEmil Barner Dalgaard, Dorte Dalsgaard Pedersen, Krogh Niels Steen, Merete Lund Hetland

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
TidsskriftAnnals of the Rheumatic Diseases
Vol/bind76
Udgave nummerSuppl. 2
ISSN0003-4967
DOI
StatusUdgivet - 16. jun. 2017
BegivenhedAnnual European Congress of Rheumatology 2017: Held by the European League Aganst Rheumatism - Madrid, Spanien
Varighed: 14. jun. 201717. jun. 2017

Konference

KonferenceAnnual European Congress of Rheumatology 2017
LandSpanien
ByMadrid
Periode14/06/201717/06/2017

Citer dette

Glintborg, Bente ; Sørensen, Inge Juul ; Loft, Anne Gitte ; Espesen, Jakob ; Jensen, Dorte Vendelbo ; Danebod, Kamilla ; Dieperink, Sabine Sparre ; Hendricks, Oliver ; Jensen Hansen, Inger Marie ; Linauskas, Asta ; Kristensen, Salome ; Andersen, Lis Smedegaard ; Hossein, Mohammad ; Nordin, Henrik ; Andersen, Birgitte Lange ; Chrysidis, Stavros ; Raun, Johnny Lillelund ; Lindegaard, Hanne Merete ; Manilo, Natalia ; Grydehøj, Jolanta ; Dalgaard, Emil Barner ; Dalsgaard Pedersen, Dorte ; Niels Steen, Krogh ; Hetland, Merete Lund. / Clinical outcomes of a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months' follow-up. Results from the DANBIO registry. I: Annals of the Rheumatic Diseases. 2017 ; Bind 76, Nr. Suppl. 2.
@article{2cc68adc28f54e799f815b5808a53b91,
title = "Clinical outcomes of a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months' follow-up. Results from the DANBIO registry.",
author = "Bente Glintborg and S{\o}rensen, {Inge Juul} and Loft, {Anne Gitte} and Jakob Espesen and Jensen, {Dorte Vendelbo} and Kamilla Danebod and Dieperink, {Sabine Sparre} and Oliver Hendricks and {Jensen Hansen}, {Inger Marie} and Asta Linauskas and Salome Kristensen and Andersen, {Lis Smedegaard} and Mohammad Hossein and Henrik Nordin and Andersen, {Birgitte Lange} and Stavros Chrysidis and Raun, {Johnny Lillelund} and Lindegaard, {Hanne Merete} and Natalia Manilo and Jolanta Grydeh{\o}j and Dalgaard, {Emil Barner} and {Dalsgaard Pedersen}, Dorte and {Niels Steen}, Krogh and Hetland, {Merete Lund}",
year = "2017",
month = "6",
day = "16",
doi = "10.1136/annrheumdis-2017-eular.1703",
language = "English",
volume = "76",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "B M J Group",
number = "Suppl. 2",

}

Glintborg, B, Sørensen, IJ, Loft, AG, Espesen, J, Jensen, DV, Danebod, K, Dieperink, SS, Hendricks, O, Jensen Hansen, IM, Linauskas, A, Kristensen, S, Andersen, LS, Hossein, M, Nordin, H, Andersen, BL, Chrysidis, S, Raun, JL, Lindegaard, HM, Manilo, N, Grydehøj, J, Dalgaard, EB, Dalsgaard Pedersen, D, Niels Steen, K & Hetland, ML 2017, 'Clinical outcomes of a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months' follow-up. Results from the DANBIO registry.', Annals of the Rheumatic Diseases, bind 76, nr. Suppl. 2. https://doi.org/10.1136/annrheumdis-2017-eular.1703

Clinical outcomes of a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months' follow-up. Results from the DANBIO registry. / Glintborg, Bente; Sørensen, Inge Juul; Loft, Anne Gitte; Espesen, Jakob; Jensen, Dorte Vendelbo; Danebod, Kamilla; Dieperink, Sabine Sparre; Hendricks, Oliver; Jensen Hansen, Inger Marie; Linauskas, Asta; Kristensen, Salome; Andersen, Lis Smedegaard; Hossein, Mohammad; Nordin, Henrik; Andersen, Birgitte Lange; Chrysidis, Stavros; Raun, Johnny Lillelund; Lindegaard, Hanne Merete; Manilo, Natalia; Grydehøj, Jolanta; Dalgaard, Emil Barner; Dalsgaard Pedersen, Dorte; Niels Steen, Krogh; Hetland, Merete Lund.

I: Annals of the Rheumatic Diseases, Bind 76, Nr. Suppl. 2, 16.06.2017.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

TY - ABST

T1 - Clinical outcomes of a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months' follow-up. Results from the DANBIO registry.

AU - Glintborg, Bente

AU - Sørensen, Inge Juul

AU - Loft, Anne Gitte

AU - Espesen, Jakob

AU - Jensen, Dorte Vendelbo

AU - Danebod, Kamilla

AU - Dieperink, Sabine Sparre

AU - Hendricks, Oliver

AU - Jensen Hansen, Inger Marie

AU - Linauskas, Asta

AU - Kristensen, Salome

AU - Andersen, Lis Smedegaard

AU - Hossein, Mohammad

AU - Nordin, Henrik

AU - Andersen, Birgitte Lange

AU - Chrysidis, Stavros

AU - Raun, Johnny Lillelund

AU - Lindegaard, Hanne Merete

AU - Manilo, Natalia

AU - Grydehøj, Jolanta

AU - Dalgaard, Emil Barner

AU - Dalsgaard Pedersen, Dorte

AU - Niels Steen, Krogh

AU - Hetland, Merete Lund

PY - 2017/6/16

Y1 - 2017/6/16

U2 - 10.1136/annrheumdis-2017-eular.1703

DO - 10.1136/annrheumdis-2017-eular.1703

M3 - Conference abstract in journal

VL - 76

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - Suppl. 2

ER -